Literature DB >> 602952

Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients.

A L Baltch, P E Griffin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 602952

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  23 in total

1.  Characteristics of Pseudomonas aeruginosa strains causing septicemia in a Spanish hospital 1981-1990.

Authors:  F Vázquez; M C Mendoza; M H Villar; A Vindel; F J Méndez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

Review 2.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

Authors:  L H Bopp; A L Baltch; M C Hammer; M A Franke; R P Smith; F Lutz
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

4.  Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test.

Authors:  I Braveny; K Machka; D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

5.  Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs.

Authors:  W Seeger; D Walmrath; H Neuhof; F Lutz
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

6.  Unusual presentation of pseudomonas infection.

Authors:  M J Weinbren; G Forgeson; G Helenglass; B Jameson; R Powles
Journal:  BMJ       Date:  1988-10-22

7.  In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics.

Authors:  D H Wu; A L Baltch; R P Smith
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.

Authors:  L R Peterson; D N Gerding; J A Moody; C E Fasching
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

9.  Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.

Authors:  C M Bassey; A L Baltch; R P Smith; P E Conley
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

10.  Multiple FadD acyl-CoA synthetases contribute to differential fatty acid degradation and virulence in Pseudomonas aeruginosa.

Authors:  Yun Kang; Jan Zarzycki-Siek; Chad B Walton; Michael H Norris; Tung T Hoang
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.